Interactive Financial Charts Not Available

TriSalus Life (TLSI) | Financial Analysis & Statements

TriSalus Life Sciences Inc. | Micro-cap | Healthcare

$4.96

-3.12%

TriSalus Life vs Abbott Laboratories TriSalus Life vs Boston Scientific TriSalus Life vs Cerus TriSalus Life vs Outset Medical TriSalus Life vs Quanterix TriSalus Life vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 11.2M

Gross Profit 9.4M 83.93%

Operating Income -7.3M -65.39%

Net Income -8.3M -73.91%

EPS (Diluted) $-0.27

Balance Sheet Metrics

Total Assets 28.6M

Total Liabilities 63.0M

Shareholders Equity -34.4M

Cash Flow Metrics

Operating Cash Flow -6.0M

Free Cash Flow -5.3M

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

TriSalus Life Income Statement From 2021 to 2024

Metric	2024	2023	2022	2021
Revenue i	29.4M	18.5M	12.4M	8.4M
Cost of Goods Sold i	4.1M	2.6M	2.3M	1.2M
Gross Profit i	25.3M	15.9M	10.1M	7.2M
Gross Margin % i	86.1%	85.9%	81.8%	85.8%
Operating Expenses
Research & Development i	17.7M	29.5M	21.4M	14.2M
Selling, General & Administrative i	43.8M	40.5M	25.2M	17.0M
Other Operating Expenses i	-	-	-	-
Total Operating Expenses i	61.5M	70.1M	46.6M	31.2M
Operating Income i	-36.2M	-54.2M	-36.4M	-24.0M
Operating Margin % i	-122.9%	-292.5%	-293.9%	-286.1%
Non-Operating Items
Interest Income i	404.0K	431.0K	180.0K	0
Interest Expense i	3.1M	16.0K	1.0K	1.8M
Other Non-Operating Income	8.8M	-5.3M	-10.9M	-3.0M
Pre-tax Income i	-30.0M	-59.0M	-47.2M	-28.8M
Income Tax i	6.0K	9.0K	9.0K	3.0K
Effective Tax Rate % i	0.0%	0.0%	0.0%	0.0%
Net Income i	-30.0M	-59.0M	-47.2M	-28.8M
Net Margin % i	-102.1%	-318.9%	-380.6%	-343.4%
Key Metrics
EBITDA i	-35.3M	-57.7M	-44.6M	-22.8M
EPS (Basic) i	$-1.31	$-6.73	$-161.55	$-93.17
EPS (Diluted) i	$-1.31	$-6.73	$-161.55	$-93.17
Basic Shares Outstanding i	25331753	9395748	309609	309609
Diluted Shares Outstanding i	25331753	9395748	309609	309609

Income Statement Trend

TriSalus Life Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets
Cash & Equivalents i	8.5M	11.8M	9.4M	30.3M	1.3M
Short-term Investments i	-	-	-	-	-
Accounts Receivable i	5.1M	3.6M	1.6M	1.4M	-
Inventory i	4.0M	2.5M	1.5M	1.3M	-
Other Current Assets	-	-	-	-	-
Total Current Assets i	20.7M	20.9M	17.2M	35.1M	2.0M
Non-Current Assets
Property, Plant & Equipment i	1.2M	1.2M	1.4M	12.0K	-
Goodwill i	-	1.1M	802.0K	794.0K	-
Intangible Assets i	-	-	-	-	-
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	423.0K	466.0K	367.0K	115.0K	250.0M
Total Non-Current Assets i	3.3M	4.9M	4.8M	2.7M	250.0M
Total Assets i	24.0M	25.7M	22.0M	37.8M	252.0M
Liabilities
Current Liabilities
Accounts Payable i	2.3M	3.4M	4.9M	1.3M	-
Short-term Debt i	216.0K	351.0K	370.0K	-	-
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	383.0K	389.0K	20.7M	104.0K	-
Total Current Liabilities i	10.2M	14.7M	32.4M	6.4M	103.2K
Non-Current Liabilities
Long-term Debt i	23.4M	1.2M	1.6M	0	-
Deferred Tax Liabilities i	-	-	-	-	-
Other Non-Current Liabilities	16.2M	35.7M	369.0K	561.0K	-
Total Non-Current Liabilities i	39.6M	37.0M	166.0M	161.1M	8.8M
Total Liabilities i	49.9M	51.7M	198.3M	167.4M	8.9M
Equity
Common Stock i	3.0K	2.0K	0	11.0K	238.2M
Retained Earnings i	-279.5M	-248.4M	-186.4M	-136.3M	-105.2K
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	-25.9M	-25.9M	-176.3M	-129.6M	243.2M
Key Metrics
Total Debt i	23.6M	1.6M	2.0M	0	0
Working Capital i	10.4M	6.2M	-15.1M	28.8M	1.9M

Balance Sheet Composition

TriSalus Life Cash Flow Statement From 2021 to 2024

Metric	2024	2023	2022	2021
Operating Activities
Net Income i	-30.0M	-59.0M	-47.2M	-28.8M
Depreciation & Amortization i	744.0K	702.0K	398.0K	464.0K
Stock-Based Compensation i	5.4M	1.4M	368.0K	109.0K
Working Capital Changes i	-7.9M	-292.0K	4.9M	1.7M
Operating Cash Flow i	-41.5M	-62.2M	-32.2M	-20.4M
Investing Activities
Capital Expenditures i	-345.0K	-588.0K	-655.0K	-1.1M
Acquisitions i	-	-	-	-
Investment Purchases i	-	-	-	-
Investment Sales i	-	-	-	-
Investing Cash Flow i	-345.0K	-1.6M	-1.7M	-2.1M
Financing Activities
Share Repurchases i	-	-	-	-
Dividends Paid i	-	-	-	-
Debt Issuance i	25.0M	-	0	45.0K
Debt Repayment i	-84.0K	-87.0K	-131.0K	-1.3M
Financing Cash Flow i	37.9M	44.8M	13.4M	50.7M
Free Cash Flow i	-41.2M	-51.2M	-33.1M	-24.0M
Net Change in Cash i	-4.0M	-18.9M	-20.5M	28.2M

Cash Flow Trend

TriSalus Life Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 0.09

Forward P/E -4.25

Price to Book -8.67

Price to Sales 6.94

PEG Ratio 0.00

Profitability Ratios

Profit Margin -86.61%

Operating Margin -65.39%

Return on Equity 128.34%

Return on Assets -52.51%

Financial Health

Current Ratio 4.08

Debt to Equity -1.73

Beta 0.48

Per Share Data

EPS (TTM) $-1.15

Book Value per Share $-0.51

Revenue per Share $1.25

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
tlsi	249.8M	0.09	-8.67	128.34%	-86.61%	-1.73
Abbott Laboratories	229.3B	16.53	4.53	30.93%	32.43%	26.50
Boston Scientific	153.7B	61.76	6.85	11.55%	13.55%	53.09
Cerus	237.7M	-10.82	4.29	-35.56%	-9.81%	176.07
Outset Medical	237.2M	-0.36	1.57	-87.65%	-82.06%	63.59
Quanterix	233.7M	-4.91	0.67	-22.41%	-56.05%	12.15

Financial data is updated regularly. All figures are in the company's reporting currency.